image
Immunovant, Inc. IMVT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 14.39
-1.3 %
$ 2.44 B
Market Cap
-5.49
P/E
Price Target Average
250.94%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
35.01%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Immunovant, Inc.
image
Wall Street analysts predict an average 1-year price target for IMVT of $50.5 , with forecasts ranging from a low of $46 to a high of $57 .
IMVT Lowest Price Target Wall Street Target
46 USD 219.67%
IMVT Average Price Target Wall Street Target
50.5 USD 250.94%
IMVT Highest Price Target Wall Street Target
57 USD 296.11%
Price
Max Price Target
Min Price Target
Average Price Target
60605555505045454040353530302525202015151010May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart IMVT

image
$800.0m$800.0m$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart IMVT

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart IMVT

image
$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)202420242025202520262026202720272028202820292029